Advancing the state’s use of technology to better understand, treat and prevent disease is the motivation behind California Governor Jerry Brown’s establishment of his Advisory Committee on Precision Medicine.
Figures from biotech, the technology sector, health authorities and other areas make up the committee, which will advise on policy issues such as data sharing and data privacy within and across technology platforms and tools, clinical utility of precision medicine approaches to care and the economic impact and sustainability of these new treatments.
The committee will provide recommendations on further actions the public and private sectors can take to integrate precision medicine into health care.
Governor Brown announced the California Initiative to Advance Precision Medicine in April 2015 as the first-in-the-nation, state-level effort to pay for focused precision medicine projects to improve care and treatment for specific diseases, and since then $13 million has been invested by the state into the fund.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze